Stocks · Health care · Pharmaceutical Preparations

OnKure Therapeutics, Inc.

OKUR Clue Score34
United States Fiscal year ends December CIK 0001637715 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

6 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Acorn Bioventures, L.p.
10% owner
—
—
—
2,839,674
$8.45M
+97.2%
Isaac Manke
Director
—
—
—
20,583
$61.22K
—
Jason A. Leverone
Chief Financial Officer
—
—
—
18,500
$55.02K
−21.1%
Edward T Mathers
Director
—
—
—
15,310
$45.54K
—
Nicholas A Saccomano
President and CEO
—
—
—
11,160
$33.19K
−11.1%
Cormorant Asset Management, LP entity
Former 10% Owner
—
—
—
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 3.0 over the window, from 13,673,565 to 40,496,309 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.